|Daily Range||$30.85 - $33.23|
|52-Week Range||$8.07 - $39.68|
|Dividend (Yield)||$0.00 (0.0%)|
|Average Daily Volume||1,854,269|
|Current FY EPS||$0.25|
How do you think NPSP
will perform against the market?
Top NPSP Bull/Bear Pitches
zzlangerhans (< 20)
Submitted November 22, 2011
Recent bad news from the STEPS 2 extension study of Gattex in short bowel syndrome got me out of the red zone and into a winning red thumb on NPS. The company reported three cases of cancer occurring … More
cashsage (< 20)
Submitted December 17, 2009
NPSP has an illiquid balance sheet and a too high valuation compared to its sales potential. It is also loss making at least until 2011.
NPS Pharmaceuticals, Inc. (NPSP) Description
A biopharmaceutical company focused on the development and commercialization of small molecule drugs and recombinant proteins. Website: http://www.npsp.com/